Trevena Drug Patent Portfolio
Trevena owns 1 orange book drug protected by 5 US patents Given below is the list of Trevena's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11077098 | Opioid receptor ligands and methods of using and making same | 23 Mar, 2032 | Active |
| US11931350 | Opioid receptor ligands and methods of using and making same | 23 Mar, 2032 | Active |
| US8835488 | Opioid receptor ligands and methods of using and making same | 23 Mar, 2032 | Active |
| US9309234 | Opioid receptor ligands and methods of using and making same | 23 Mar, 2032 | Active |
| US9642842 | Opioid receptor ligands and methods of using and making same | 23 Mar, 2032 | Active |
Latest Legal Activities on Trevena's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Trevena.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Patent eGrant Notification | 19 Mar, 2024 | US11931350 |
|
Email Notification
Critical
| 19 Mar, 2024 | US11931350 |
| Recordation of Patent eGrant | 19 Mar, 2024 | US11931350 |
|
Recordation of Patent Grant Mailed
Critical
| 19 Mar, 2024 | US11931350 |
| Mail Patent eGrant Notification | 19 Mar, 2024 | US11931350 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 19 Mar, 2024 | US11931350 |
|
Email Notification
Critical
| 29 Feb, 2024 | US11931350 |
|
Issue Notification Mailed
Critical
| 28 Feb, 2024 | US11931350 |
| Filing Receipt - Corrected | 06 Feb, 2024 | US11931350 |
|
Email Notification
Critical
| 06 Feb, 2024 | US11931350 |
|
Application Is Considered Ready for Issue
Critical
| 05 Feb, 2024 | US11931350 |
| Dispatch to FDC | 05 Feb, 2024 | US11931350 |
|
Issue Fee Payment Received
Critical
| 01 Feb, 2024 | US11931350 |
| Response to Reasons for Allowance | 01 Feb, 2024 | US11931350 |
|
Issue Fee Payment Verified
Critical
| 01 Feb, 2024 | US11931350 |
Trevena Drug Patents' Oppositions Filed in EPO
Trevena drug patents have faced multiple oppositions in the European Patent Office. The earliest opposition was filed on Feb 28, 2018, by Generics (Uk) Ltd. This opposition was filed on patent number EP12760456A. Click below to reveal the latest opposition data.
| Application | Filing Date | Opposition Party | Legal Status |
|---|---|---|---|
 | |||
| EP12760456A | Feb, 2018 | Generics (UK) Ltd | Opposition rejected |
Trevena's Family Patents
Trevena Drug List
Given below is the complete list of Trevena's drugs and the patents protecting them.
1. Olinvyk
Olinvyk is protected by 5 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11077098 | Opioid receptor ligands and methods of using and making same |
23 Mar, 2032
(6 years from now)
| Active |
| US11931350 | Opioid receptor ligands and methods of using and making same |
23 Mar, 2032
(6 years from now)
| Active |
| US8835488 | Opioid receptor ligands and methods of using and making same |
23 Mar, 2032
(6 years from now)
| Active |
| US9309234 | Opioid receptor ligands and methods of using and making same |
23 Mar, 2032
(6 years from now)
| Active |
| US9642842 | Opioid receptor ligands and methods of using and making same |
23 Mar, 2032
(6 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Olinvyk's drug page